News Channels

22 Jan 2020 Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers
22 Jan 2020 INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA
22 Jan 2020 Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients
22 Jan 2020 Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
22 Jan 2020 Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
22 Jan 2020 LB Pharmaceuticals Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of LB-102, a Novel Benzamide for the Treatment of Schizophrenia
22 Jan 2020 Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
22 Jan 2020 Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
22 Jan 2020 Ra Pharmaceuticals Announces Clearance of IND Application for the HEALEY ALS Platform Trial
22 Jan 2020 Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD
22 Jan 2020 Targovax Announces Encouraging Data in Mesothelioma Study Combining ONCOS-102 and Standard of Care Chemotherapy
22 Jan 2020 FDA Approves TEPEZZA (TM) (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
22 Jan 2020 PDC*line Pharma raises €20 million in Series B financing round
21 Jan 2020 Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund
21 Jan 2020 BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis
21 Jan 2020 Rafael Pharmaceuticals Announces the Initiation of a Phase 1b/2 Clinical Trial of CPI-613 (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
21 Jan 2020 Stealth BioTherapeutics Initiates First-in-Human Study of SBT-272
21 Jan 2020 Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
21 Jan 2020 Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 INVIGORATE Trial in Allergic Conjunctivitis
21 Jan 2020 Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up